Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Pfizer Ltd

PFIZER.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Mid Cap Analyst: BUY

Last Close

$51.08

▼ -2.32%

Market Cap $2.34B · Vol 11.70K

Key Metrics

P/E Ratio

30.34

FWD: 25.92

Market Cap

$2.34B

Mid Cap

Div Yield

1.54%

Annual dividend

EPS Growth

+7.05%

YoY

RSI (14)

64.38

Momentum

Beta

0.73

vs Market

52W High

$61.54

24.09% below

52W Low

$45.68

10.81% above

Volume

11.70K

Avg 33.23K

P/B

5.14

Price-to-book

ROE

18.33%

Return on equity

Free Float

33.05%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Pfizer Ltd (PFIZER.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PFIZER.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.12%

+4.51%

+4.14%

-3.23%

YTD

-2.26%

-8.51%

+13.00%

-12.60%

Financials & Valuation

TTM · Annual

Total Revenue	$269.61M
Net Income	$77.30M
Revenue Growth (YoY)	+8.31%
Gross Margin	60.46%
Operating Margin	33.62%
Net Profit Margin	28.67%
ROE	18.33%
ROA · ROIC	19.84% · 16.93%

P/E Ratio	30.34
Forward P/E (FY1)	25.92
PEG Ratio	-5.08
P/S	8.57
P/B	5.14
P/FCF	19.44
EPS Growth	+7.05%
Outstanding Shares	45.75M

Technical Indicators

50-Day SMA	$48.70
200-Day SMA	$50.46
RSI (14)	64.38
Beta	0.73
52-Week High	$61.54
52-Week Low	$45.68

Volume Today	11.70K
Avg Daily Volume (30D)	33.23K
Relative Volume	0.35x
Volatility (10D)	20.81
Volatility (30D)	19.34
Free Float	33.05%

Analyst Consensus

BUY

Current Price $51.08

Mean Target $66.51

52W Low$45.68 52W High$61.54

Current

Target

$45.68 $61.54

Current Analyst target

+30.21% upside potential · 5 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S849S5

ISININE182A01018

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 10, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Pfizer Limited (Pfizer) is an India-based multinational pharmaceutical company focusing on therapy in four business categories, namely, Vaccines, Hospitals, Internal Medicine, and Inflammation and Immunology. Pfizer’s Vaccines Division focuses on Prevenar 13, a Pneumococcal Conjugate Vaccine approved for administering to individuals of all ages against pneumococcal disease, an infection caused by streptococcus pneumoniae bacteria. Internal Medicine portfolio includes approximately 17 specialties and seven therapy areas, including respiratory, multivitamin and multimineral, gastrointestinal, pain, neuroscience, cardiovascular and women’s healthcare. Pfizer Hospital Business Unit focuses on providing advanced anti-infectives to institutions such as hospitals and nursing homes. Inflammation and Immunology focuses on discovering and developing novel therapeutics for chronic autoimmune diseases. Its brands include Prevenar13, CorexDX, Dolonex, Enbrel, Becosules and Folvite, among others.